1. Home
  2. NNDM vs CLLS Comparison

NNDM vs CLLS Comparison

Compare NNDM & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

HOLD

Current Price

$1.77

Market Cap

368.1M

Sector

Technology

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$3.48

Market Cap

438.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNDM
CLLS
Founded
2012
1999
Country
United States
France
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.1M
438.4M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
NNDM
CLLS
Price
$1.77
$3.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
2.6M
42.4K
Earning Date
11-19-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,663,000.00
$82,551,000.00
Revenue This Year
N/A
$32.58
Revenue Next Year
N/A
$20.68
P/E Ratio
N/A
N/A
Revenue Growth
26.75
129.04
52 Week Low
$1.31
$1.10
52 Week High
$2.69
$5.48

Technical Indicators

Market Signals
Indicator
NNDM
CLLS
Relative Strength Index (RSI) 48.01 31.59
Support Level $1.77 $4.04
Resistance Level $1.97 $3.95
Average True Range (ATR) 0.10 0.21
MACD -0.01 -0.07
Stochastic Oscillator 26.42 5.66

Price Performance

Historical Comparison
NNDM
CLLS

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: